Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Parsons

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 8, 2012
Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-onesTiansheng Wang, Leonard Duncan, Wenxin Gu, et al.
Antiviral Therapy|July 27, 2024
Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohortCourtney N Nichols, Mark Lustberg, Mohammed Mahdee E Sobhanie, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2012
Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamidesWenxin Gu, Tiansheng Wang, Francois Maltais, et al.
Heart (British Cardiac Society)|October 13, 2010
Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variantsHelen R Griffin, Ana Töpf, Elise Glen, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitorsUpul Bandarage, Brian Hare, Jonathan Parsons, et al.
Hospital Pharmacy|September 9, 2022
Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency DepartmentElizabeth Rozycki, Ashley Weiner, Carlos Malvestutto, et al.
BMC Genetics|June 21, 2013
Low-frequency intermediate penetrance variants in the ROCK1 gene predispose to Tetralogy of FallotJulian Palomino Doza, Ana Topf, Jamie Bentham, et al.
The Journal of Allergy and Clinical Immunology|September 26, 2016
Exercise-induced bronchoconstriction update-2016John M Weiler, John D Brannan, Christopher C Randolph, et al.
Circulation. Cardiovascular Genetics|April 17, 2012
A common variant in the PTPN11 gene contributes to the risk of tetralogy of FallotJudith A Goodship, Darroch Hall, Ana Topf, et al.
Plos One|March 25, 2009
Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformationHelen R Griffin, Darroch H Hall, Ana Topf, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|May 8, 2012
Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-onesTiansheng Wang, Leonard Duncan, Wenxin Gu, et al.
Antiviral Therapy|July 27, 2024
Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohortCourtney N Nichols, Mark Lustberg, Mohammed Mahdee E Sobhanie, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2012
Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamidesWenxin Gu, Tiansheng Wang, Francois Maltais, et al.
Heart (British Cardiac Society)|October 13, 2010
Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variantsHelen R Griffin, Ana Töpf, Elise Glen, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitorsUpul Bandarage, Brian Hare, Jonathan Parsons, et al.
Hospital Pharmacy|September 9, 2022
Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency DepartmentElizabeth Rozycki, Ashley Weiner, Carlos Malvestutto, et al.
BMC Genetics|June 21, 2013
Low-frequency intermediate penetrance variants in the ROCK1 gene predispose to Tetralogy of FallotJulian Palomino Doza, Ana Topf, Jamie Bentham, et al.
The Journal of Allergy and Clinical Immunology|September 26, 2016
Exercise-induced bronchoconstriction update-2016John M Weiler, John D Brannan, Christopher C Randolph, et al.
Circulation. Cardiovascular Genetics|April 17, 2012
A common variant in the PTPN11 gene contributes to the risk of tetralogy of FallotJudith A Goodship, Darroch Hall, Ana Topf, et al.
Plos One|March 25, 2009
Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformationHelen R Griffin, Darroch H Hall, Ana Topf, et al.
Pageof 3